BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Etilefrine

A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.

169+ PubMed studies analyzed · 21 RCTs · Evidence Score: 52.3

Research Domains

Etilefrine has been studied across 16 research domains including ❤️ Cardiovascular, 🧠 Focus & Attention, 😴 Sleep, 🔬 Oncology, 🫘 Kidney. The primary research focus is ❤️ Cardiovascular with 22% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Etilefrine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Salmeterol
2 shared targets
bufo
2 shared targets
dendrobium
2 shared targets
lycopus
2 shared targets
mylabris
2 shared targets
anemarrhena
2 shared targets
curculigo
2 shared targets
gentiana
2 shared targets
platycodon
2 shared targets
Rubia
2 shared targets
Loading evidence profile...

This evidence profile for Etilefrine is generated deterministically from 169 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.